These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21830405)

  • 1. Effectiveness of intraperitoneal hyperthermo-chemotherapy for malignant peritoneal mesothelioma and estimation of its effect by repeated FDG-PET: a case report.
    Yamaguchi S; Asao T; Tsutsumi S; Fujii T; Yamauchi H; Kigure W; Morita H; Yajima R; Suto T; Kuwano H
    Hepatogastroenterology; 2011; 58(107-108):861-4. PubMed ID: 21830405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    Yan TD; Haveric N; Carmignani CP; Chang D; Sugarbaker PH
    Cancer; 2005 Feb; 103(4):839-49. PubMed ID: 15637690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma.
    Cao Q; Lu M; Heath J; Hausner PF; Alexander HR; Dilsizian V; Chen W
    Clin Nucl Med; 2012 May; 37(5):492-4. PubMed ID: 22475902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Pfannenberg C; Königsrainer I; Aschoff P; Oksüz MO; Zieker D; Beckert S; Symons S; Nieselt K; Glatzle J; Weyhern CV; Brücher BL; Claussen CD; Königsrainer A
    Ann Surg Oncol; 2009 May; 16(5):1295-303. PubMed ID: 19252950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia].
    Gómez Portilla A; Cendoya I; Muriel J; Olabarria I; Guede N; Moraza N; Fernández E; Martínez de Lecea C; Magrach L; Martín E; Romero E; Aguado I; Valdovinos M; Larrabide I
    Cir Esp; 2007 Feb; 81(2):82-6. PubMed ID: 17306123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological predictors of complete cytoreduction in 59 patients with peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a UK referral centre.
    Chandramohan A; Thrower A; Shah N; Mohamed F
    Br J Radiol; 2017 Nov; 90(1079):20170361. PubMed ID: 28830230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ['Malignant peritoneal mesothelioma': a condition difficult to diagnose].
    van der Valk FM; van Leeuwen J
    Ned Tijdschr Geneeskd; 2012; 156(15):A4269. PubMed ID: 22495008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant peritoneal mesothelioma.
    Loggie BW
    Curr Treat Options Oncol; 2001 Oct; 2(5):395-9. PubMed ID: 12057102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
    Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
    Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal Cancer Index by (18)F-FDG PET/TC pre and post-hyperthermic intraperitoneal chemotherapy. Report of a case.
    Garcia JR; Villasboas-Rosciolesi D; Soler M; Bassa P; Cozar M; Riera E
    Rev Esp Med Nucl Imagen Mol; 2016; 35(5):329-31. PubMed ID: 27036888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant peritoneal mesothelioma].
    Cardoso C; Gamito E; Quintana C; Oliveira AP
    Acta Med Port; 2011 Dec; 24 Suppl 3():689-94. PubMed ID: 22856414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
    Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma.
    Dubreuil J; Giammarile F; Rousset P; Rubello D; Bakrin N; Passot G; Isaac S; Glehen O; Skanjeti A
    Nucl Med Commun; 2017 Apr; 38(4):312-318. PubMed ID: 28244976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of peritoneal malignant mesothelioma that FDG-PET was useful for a supporting diagnosis].
    Gotoh Y; Kawasaki A; Yamaguchi Y; Ishibashi K; Higashi T; Morita H; Yamasaki M
    Nihon Shokakibyo Gakkai Zasshi; 2005 Jul; 102(7):929-33. PubMed ID: 16038442
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of disease progression on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients with malignant pleural mesothelioma undergoing multimodality therapy with pleurectomy/decortication.
    Bille A; Chicklore S; Okiror L; Cook GJ; Spicer J; Landau D; Lang-Lazdunski L
    Nucl Med Commun; 2013 Nov; 34(11):1075-83. PubMed ID: 23963351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal mesothelioma.
    Esquivel J; Averbach A
    J Laparoendosc Adv Surg Tech A; 2009 Aug; 19(4):505-7. PubMed ID: 19405805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma.
    Tan C; Barrington S; Rankin S; Landau D; Pilling J; Spicer J; Cane P; Lang-Lazdunski L
    J Thorac Oncol; 2010 Mar; 5(3):385-8. PubMed ID: 20087231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse malignant peritoneal mesothelioma--an update on treatment.
    Mirarabshahii P; Pillai K; Chua TC; Pourgholami MH; Morris DL
    Cancer Treat Rev; 2012 Oct; 38(6):605-12. PubMed ID: 22104079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerning CT features predict outcome of treatment in patients with malignant peritoneal mesothelioma.
    Sugarbaker PH; Chang D; Jelinek JS
    Eur J Surg Oncol; 2021 Sep; 47(9):2212-2219. PubMed ID: 33888394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 18F-FDG PET/CT in the staging of pediatric peritoneal mesothelioma.
    Abikhzer G; Gourevich K; Arkovitz M; Postovsky S; Keidar Z
    Clin Nucl Med; 2013 Aug; 38(8):e331-2. PubMed ID: 23478845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.